International
September 12, 2008 – The U.S. Food and Drug Administration today announced the approval of the vaccine GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] for the prevention of vaginal and vulvar cancer caused by Human Papillomavirus (HPV) types 16 and 18 in girls and women ages 9 to 26. These two HPV types cause 70 percent of cervical cancers, and are known to also cause some vulvar and vaginal cancers, but the percentages are not well defined.
Rated 0.00 | 12 Views
By NewsInfusion
Rated 3.78 | 11,094 Views
By MultiVu
Rated 3.39 | 4,268 Views
By MultiVu
Avon Walk For Breast Cancer 2007
Rated 3.81 | 931 Views
By uchau
Rated 3.59 | 1,891 Views
By mantalk
How Your Video Game System Can Help Cure C...ancer
Rated 2.05 | 1,851 Views
By Medialink
Breakthrough Vaccine to Treat Advanced Sta...ges of Ovarian Cancer
Rated 1.78 | 545 Views
By Medialink
Rated 2.33 | 1,530 Views
New Resources Help Answer Questions About...Colorectal Cancer
Rated 2.41 | 192 Views
By Medialink
Yul Brynner Foundation Kicks Off Oral, Hea...d And Neck Cancer Awar
Rated 2.00 | 702 Views
By MultiVu
Important News In the Fight Against Breast...Cancer
Rated 2.29 | 2,136 Views
By MultiVu
Rated 3.26 | 1,677 Views
By tumaini
Important News in the Fight Against Breast...Cancer
Rated 2.48 | 2,183 Views
By MultiVu
Important News in the Fight Against Breast...Cancer
Rated 2.59 | 2,421 Views
By MultiVu
Important News in the Fight Against Breast...Cancer
Rated 2.46 | 1,993 Views
By MultiVu
Rated 2.72 | 3,201 Views
By cathealth